← Back to headlines
AxoGen Touts FDA BLA Win, Targets 18% Growth and Wider Nerve Repair Adoption at Raymond James Conference
6 Mar, 02:07 — 6 Mar, 02:07
Sources
Showing 1 of 1 sources
Related Stories
Cyclospora Outbreak Linked to Iceberg Lettuce Expands to Three Additional States
2h ago
Australian Woman Gives Birth to Twins Fathered by Two Different Men
4h ago
U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates
9h ago
West Nile Virus Outbreaks Spread Across Greece and North Macedonia
9h ago